The therapeutic robots market is valued at USD 964.4 million in 2025 and is expected to reach USD 7,102.6 million by 2035, with a CAGR of 22.1%. The market’s rapid growth is driven by increasing adoption of robotics in healthcare settings, particularly for emotional and rehabilitation therapy, with humanoid robots leading the way with 57.8% share in 2025. As therapeutic robots become more sophisticated and cost-effective, their integration in treating patients with various physical and mental health conditions accelerates. Autism leads the disorder type segment with 38.6% market share in 2025, reflecting the growing demand for robotic support in autism therapy, where robots play a vital role in behavioral interaction and therapy delivery.
Growth is further fueled by the aging global population, increasing stroke incidents, and the rising incidence of neurodevelopmental disorders like autism. North America, Asia-Pacific, and Europe will drive market expansion due to robust healthcare infrastructure and high disposable income, supporting the adoption of therapeutic robots for conditions like dementia, anxiety, and post-traumatic stress. Technological advances in robotics, such as enhanced emotional interaction capabilities, will continue to drive market demand. However, challenges such as high initial costs, regulatory hurdles, and limited reimbursement models in certain regions may hinder widespread adoption.
| Metric | Value |
|---|---|
| Therapeutic Robots Market Estimated Value in (2025 E) | USD 964.4 million |
| Therapeutic Robots Market Forecast Value in (2035 F) | USD 7102.6 million |
| Forecast CAGR (2025 to 2035) | 22.1% |
The humanoid robot segment is poised to capture 57.8% of the market share in 2025. Humanoid robots are designed to interact with patients through human-like movements, making them ideal for therapeutic applications such as autism treatment, dementia care, and rehabilitation following stroke. Their ability to simulate human emotions and behavior enables deeper connections with patients, fostering more effective therapy outcomes. Increased interest in human-like robots that provide emotional support and interact in natural ways strengthens the demand for humanoid robots. Additionally, humanoid robots in therapeutic applications are supported by advancements in artificial intelligence (AI) and robotics, further enhancing their capabilities and performance in healthcare settings.
The autism disorder segment will dominate the market, holding 38.6% of the share in 2025. The use of therapeutic robots in autism treatment has gained significant traction due to the increasing need for alternative interventions that support behavioral therapy and cognitive development. Robots designed for autism therapy can provide consistent, personalized interaction that enhances communication and social skills in children with autism. Given the rising incidence of autism and the shortage of skilled therapists, therapeutic robots are seen as a promising tool to augment existing therapeutic practices. These robots are particularly effective in structured environments, providing patients with a safe and predictable interaction model, thus boosting their adoption in the treatment of autism globally.
The rehabilitation centers segment is expected to see substantial growth, driven by the increasing use of robotic systems in post-stroke recovery and physical rehabilitation. These robots assist in enhancing motor skills, reducing recovery time, and promoting independence in patients. The segment benefits from technological advancements, with robots offering precise, repetitive motions that humans may find difficult to perform consistently. Rehabilitation centers are increasingly adopting robotic technology to support physical therapists and improve patient outcomes, contributing to the rise in demand for therapeutic robots in clinical and home settings. As the cost of these technologies continues to decrease, more rehabilitation centers will integrate these systems into their therapy offerings.
With the growing aging population across the globe especially in countries including Japan, Italy, Germany, Singapore, the UK, the USA, and Canada, the demand for therapeutic robots is expected to subsequently increase in the coming years for emotional support.
The rise in instances of cerebral vascular accidents (stroke) in the aged population, increases the demand for the deployment of rehabilitation technologies such as therapeutic robotics to assist in the recovery process as well as to provide mental & physical support.
Moreover, the robust increase in the number of rehabilitation centers coupled with the continuous evolution of robotic technology is likely to boost the growth of the therapeutic robots market over the forecast period.
Additionally, the developed regions that have a high disposable income of individuals and the growing awareness about the utilization of robots for stress-related issues is one of the key factors that will increase the adoption of therapeutic robots.
Furthermore, not only do therapeutic robots simplify the work of a human therapist, but it also helps to reduce the cost of treatment while helping patients to deal with the social environment.
As therapeutic robots become more versatile, affordable, and sophisticated with time, they are more likely to be seen in treatment settings. These factors are projected to create significant demand for therapeutic robots in the worldwide market.
The upsurge in the adoption of innovative automated technologies in the healthcare sector, satisfactory reimbursement policies, and relatively higher per capita expenditure on healthcare, is expected to create lucrative growth opportunities, especially in developed regions such as North America and Europe. In the USA, manufacturers of therapeutic robots are increasingly focusing on developing advanced emotional therapy robots to cure neurological disorders such as autism and dementia.
For instance, recently, in 2020, Bionik Laboratories Corp. launched the InMotion arm/hand robotic system for the treatment of mobility impairments due to neurological conditions and clinical rehabilitation of stroke survivors. Similarly, PARO, a companion robot, developed by Japan’s National Institute of Advanced Industrial Science and Technology, has been designed for the recovery of patients suffering from Alzheimer’s, dementia, and other cognitive disorders.
Additionally, regions such as East Asia and South Asia are also expected to experience significant growth owing to increasing awareness about conditions such as Dementia, Alzheimer's, and Cerebral Palsy that are actively driving demand for therapeutic robots in these regions.
Therapeutic robots are a type of rehabilitation robot used as a recovery therapy for individuals suffering from various mental and physical health disorders. These robots usually replace human-applied therapies with robotics-based therapies.
Recent studies have shown that therapeutic robots, also known as emotional robots and robotic pets, are becoming popular companions for people with cognitive impairment or/and physical disabilities. The use of therapeutic robots in autism, mood disorders, and Alzheimer's care has shown considerable promise.
In the coming years, the market for therapeutic robots is projected to grow due to a change from conventional therapies for people with disabilities to robotic therapy, which helps optimize their recovery.
The global therapeutic robots market has numerous small-scale and international manufacturers at the regional level. Few industry players are identified across the value chain of the global therapeutic robots market which are PARO Robots, SoftBank Robotics, AnthroTronix, Inc., BeatBots LLC, Omron Corporation, Sony Corporation, Bionik Laboratories Corp., Instead Technologies Ltd., Ekso Bionics Holdings Inc., AlterG, Inc.
| Report Attribute | Details |
|---|---|
| Growth rate | CAGR of 22.1% from 2025 to 2035 |
| Base year for estimation | 2024 |
| Historical data | 2020 to 2024 |
| Forecast period | 2025 to 2035 |
| Quantitative units | Revenue in USD Million/ Billion and CAGR from 2025 to 2035 |
| Report coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis |
| Segments covered | Product Type, Type of Disorder, End Use & Region |
| Regional scope | North America (USA, Canada); Latin America (Mexico, Brazil); Latin America (Mexico, Brazil); Western Europe (Germany, Italy, France, UK, Spain); Eastern Europe (Poland, Russia); Asia Pacific (China, India, ASEAN, Australia & New Zealand); Japan; Middle East and Africa (GCC Countries, S. Africa, Northern Africa) |
| Country scope | USA, Canada, Mexico, Brazil, US, Canada, Mexico, Brazil, Germany, Italy, France, U.K, Spain, Poland, Russia, China, India, ASEAN, Australia & New Zealand, Japan, GCC Countries, S. Africa, Northern Africa |
| Key companies profiled | PARO Robots; SoftBank Robotics; AnthroTronix; Inc.; BeatBots LLC; Omron Corporation; Sony Corporation; Bionik Laboratories Corp.; Instead Technologies Ltd.; Ekso Bionics Holdings Inc.; AlterG; Inc. |
| Customization scope | Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
How big is the therapeutic robots market in 2025?
The global therapeutic robots market is estimated to be valued at USD 964.4 million in 2025.
What will be the size of therapeutic robots market in 2035?
The market size for the therapeutic robots market is projected to reach USD 7,102.6 million by 2035.
How much will be the therapeutic robots market growth between 2025 and 2035?
The therapeutic robots market is expected to grow at a 22.1% CAGR between 2025 and 2035.
What are the key product types in the therapeutic robots market?
The key product types in therapeutic robots market are humanoid and pets.
Which type of disorder segment to contribute significant share in the therapeutic robots market in 2025?
In terms of type of disorder, autism segment to command 38.6% share in the therapeutic robots market in 2025.
x
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Therapeutic Robots Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
